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Abstract: The aim of the present research was to investigate the genotoxic potency of benzoyl peroxide (BPO), a whitener
of flour and cheese, using in vitro sister chromatid exchange (SCE), chromosome aberration (CA), and micronucleus
(MN) tests in human peripheral lymphocytes. Cells were exposed to 25, 50, 75, and 100 μg/mL concentrations of BPO
for 24 and 48 h. BPO induced SCEs only at the highest concentration (100 μg/mL) for 48 h treatment. Furthermore,
BPO induced CAs at 75 and 100 μg/mL concentrations for 24 h treatment, and at all concentrations for 48 h treatment.
BPO induced CAs in a dose-dependent manner for 24 and 48 h treatment periods. Increased level of MN formation
induced by BPO was only observed for the 48 h treatment period at the 2 highest concentrations (75 and 100 μg/mL).
Statistically significant reductions in the proliferation index (PI) and mitotic index (MI) were only detected in cultures
for the 48-h treatment period.
Key words: Benzoyl peroxide, human lymphocytes, sister chromatid exchange, chromosome aberration, micronucleus

İnsan periferal lenfositlerinde benzol peroksit’in in vitro genotoksik etkileri
Özet: Bu çalışmanın amacı un ve peynir beyazlatmada kullanılan benzol peroksit (BPO)’in genotoksik etkisini insan
periferal lenfositlerinde in vitro kardeş kromatid değişimi (KKD), kromozom aberasyonu (KA) ve mikronukleus (MN)
testleriyle araştırmaktır. Hücreler 25, 50, 75 ve 100 μg/mL konsantrasyondaki BPO ile 24 ve 48 saat muamele edilmiştir.
BPO KKD’yi sadece en yüksek konsantrasyonda (100 μg/mL) 48 saatlik muamelede uyarmıştır. Halbuki, BPO 24 saatlik
muamelede 75 ve 100 μg/mL konsantrasyonda, 48 saatlik muamelede tüm konsantrasyonlarda KA’yı uyarmıştır. BPO
KA’yı 24 ve 48 saatlik muamele sürelerinde doza bağlı olarak uyarmıştır. BPO tarafından mikronukleus oluşumunun
artışı sadece 48 saatlik muamele süresinde iki en yüksek konsantrasyonda (75 ve 100 μg/mL) görülmüştür. Proliferasyon
indeksi (PI) ve mitotik indeks (MI) sadece 48 saatlik muamele süresinde önemli derecede düşmüştür.
Anahtar sözcükler: Benzol peroksit, insan lenfositleri, kardeş kromatid değişimi, kromozom aberasyonu, mikronukleus

Introduction
Benzoyl peroxide (BPO), the test substance of this
study, is widely used in plastics, dyes,
pharmaceuticals, construction, cosmetics, and also in
the food industry as a whitener of flour and cheese.

Many
researchers
have
employed
the
Salmonella/Ames (Microsome) test to evaluate the
mutagenic potential of benzoyl peroxide. BPO was
reported to be non-mutagenic on Salmonella
typhimurium TA1535 and TA1537 strains in both the
15
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presence and absence of S9mix (according to Litton
Bionetics, 1975 from Binder et al.) (1). Similarly, BPO
was found to have been non-mutagenic on TA98 and
TA100 (according to Yamaguchi and Yaeuashita, 1980
from Binder et al.) and TA97, TA98, TA100, TA1535,
TA1537, TA1538, and TA102 strains in the presence
of S9mix (according to De Flora et al., 1984 from
Binder et al.) (1). Ishidate et al. (2) determined that
BPO did not induce mutations in TA98, TA100,
TA1535, or TA1537 strains (+/- S9mix). Likewise, a
negative response for the mutagenicity of BPO was
gained (+/- S9mix) for TA97 and TA102 strains
(according to Fujita and Sasaki, 1987 from SIDnitial
Assessment Report) (3). BPO dissolved in acetone did
not induce mutations (+/- S9mix) in TA97, TA98,
TA100, or TA1535 strains (according to Zerger et al.,
1988 from Binder et al.) (1). Dillon et al. (4) found
that BPO did not induce mutations in TA97, TA100,
TA102, or TA104 strains (+/- S9mix). Additionally,
BPO was non-mutagenic on Salmonella typhimurium
TA98, TA100, TA1535, and TA1537 strains (+/S9mix) (according to NIER, 2001 from SIDnitial
Assessment Report) (3).
In general, BPO was examined as non-mutagenic
on different strains of Salmonella typhimurium,
whereas it was found that BPO was an inducer of
mutagenicity in TA97 and TA1537 (-S9mix) strains
(according to Matula et al., 1987 from Binder et al.)
(1).
Epstein et al. (5) determined that BPO did not
increase dominant lethal mutations in ICR/Ha Swiss
mice. Ishidate et al. (2) noted that 0.2 mg/mL BPO did
not increase chromosomal aberrations in Chinese
hamster in vitro fibroblast cultures during 24 and 48
h treatment periods. Nevertheless, it was
demonstrated that BPO increased the SCE dose
dependently in CHO cells (Chinese hamster ovary
cells) in the presence of S9mix, while no increment
was observed for SCE in the absence of S9mix
(according to Jarventaus et al., 1984 from Binder et
al.) (1). According to another study, BPO treatment
resulted in a 1.2-fold increase in SCEs compared to
the control in Chinese Hamster V79 cells (according
to Swierenga et al., 1987 from Binder et al.) (1).
However, BPO did not induce MN formation in ICR
(SPF) mice (according to NIER, 2001 from SIDnitial
Assessment Report) (3).
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As seen from the above observations, several
researchers obtained different outcomes from the
genotoxicity studies with BPO. Generally, negative
results were recorded; however, positive results were
also reported in certain studies. Furthermore,
genotoxicity of BPO in human peripheral
lymphocytes have never been studied. For this reason,
the aim of the present study was to investigate the
possible genotoxic effects of BPO in human
peripheral lymphocytes by the in vitro sister
chromatid exchange (SCE), chromosome aberration
(CA), and micronucleus (MN) tests.
Materials and methods
Test material and reagents
In this study, peripheral blood was taken from 4
healthy donors (2 males, age 25; 2 females, age 24 and
25; both non-smokers and non-alcohol consumers)
was used as the test material. BPO was used as the test
substance of this study.
BPO was obtained from Merck (Darmstadt,
Germany). The structural formula and other
properties of BPO are shown in Figure 1. The test
substance was dissolved in dimethylsulphoxide
(DMSO, pure 99%) and DMSO was obtained from
Sigma (St. Louis MO, USA). Mitomycin C was used as
the positive control (MMC, Kyowa, Hakko, Japan,
CAS registry number: 50-07-7) and dissolved in
sterile bidistilled water. For this study, 5-

O
O

O
O

IUPAC name: Dibenzoyldioxidane
Molecular formula: C 14 H 10 O4 or (C 6 H 5 CO) 2 O 2
Molecular weight: 242.24
Density: 1.33 g/cm3 (25 °C)
Melting point: 104-106 °C
CAS No: 94-36-0
Merck Cat No: 8.01641.0100

Figure 1. The chemical formula and physical properties of
benzoyl peroxide.
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bromodeoxyuridine (B-5002), colchicine (C-9754)
and cytochalasin B (6762) were purchased from
Sigma. Giemsa and other chemicals were obtained
from Merck. All the test solutions were freshly
prepared for each experiment.
Cell culture establishment and slide preparation
for the SCE and CA assay
In this study, human peripheral lymphocytes were
treated with BPO. Fresh whole blood taken from the
above mentioned donors was added to chromosome
medium B (Biochrom F-5023; Berlin, Germany) in
sterile culture tubes and the genotoxicity of BPO was
then examined.
For the lymphocyte culture, 0.2 mL of heparinized
whole blood (1/10) taken from a healthy donor was
added to 2.5 mL of chromosome medium B and
shortly after the culture was supplemented with 5bromodeoxyuridine (a final concentration of 10
μg/mL). The cell culture was then incubated at 37 °C
for 72 h. The cells were treated with 25, 50, 75, and
100 μg/mL concentrations of benzoyl peroxide for 24
h (test substance was added 48 h after initiating the
culture) and 48 h (test substance was added 24 h after
initiating the culture). Each experiment had a control
(untreated), a solvent control (8 μL/mL DMSO, BPO
dissolves in DMSO) and a positive control (MMC
0.25 μg/mL). To arrest the cells at metaphase 0.06
μg/mL of colchicine was added to the culture 2 h
before harvesting (70th h of the culture). The cell
culture was centrifuged at the end of the 72 h
incubation (1200 rpm, 15 min). After centrifugation
cells were treated with hypotonic solution (0.4% KCl)
at 37 °C for 15 min, and then treated with cold fixative
(methanol/glacial acetic acid = 3:1 v/v) at room
temperature for 20 min. Fixative treatment was
repeated 3 times. Slides were prepared after the 3rd
fixative treatment and air dried. In order to examine
the CAs, 1-day-old slides were stained following the
standard staining methods (5% Giemsa prepared in
Sorensen buffer, pH 6.8). For SCE analysis, the slides
were stained using a modified fluorescence plus
Giemsa (FPG) (6) method. One-day-old slides were
covered with Sorensen buffer for FPG staining (pH
6.8) and irradiated under UV light (254 nm, 30 W)
for 30 min. Slides then incubated with 1× SSC buffer
at 58 to 60 °C for 60 min and stained with 5% Giemsa
(in Sorensen buffer) for 20 min. To score SCE, 25

well-spread second-division metaphase for each
donor were analyzed at 1000× magnification (totally
100 second-division metaphase for 4 donors). Mean
number of SCE per cell (SCE/cell) was calculated. To
score chromosome aberrations (CAs) 100 cells (a total
of 400 cells per concentration) for each donor were
examined at 1000× magnification. The structural and
numerical CAs were scored. However, only the
structural chromosome aberration data were used to
assess the genotoxicity. Ratio of cells bearing
structural chromosome aberrations was calculated
per donor. Structural chromosome aberrations were
classified according to ISCN as shown by Mitelman
(7) and Paz-y-Miño et al. (8). Structural chromosome
aberrations were classified as the chromatid type
(breaks, sister union, and exchanges) and the
chromosome type (breaks, fragments, dicentrics, and
rings) aberrations. Gaps were not evaluated as CA (9).
In addition, a total of 400 cells (100 cells per each
donor) were scored for proliferation index (PI). The
PI was calculated as follows: (M1 × 1) + (M2 × 2) +
(M3 × 3) / 100. M1, M2, and M3 represent the
number of cells undergoing the first, second, and
third mitosis. MI was determined by scoring 3000
cells per each donor (a total of 12,000 cells per
concentration). The number of dividing cells (cells in
metaphase) in 3000 cells was recorded. MI was
calculated according to the formula as follows: MI =
100 × cell in metaphase / 3000.
Cell culture establishment and slide preparation
for the micronucleus assay
For the analysis of MN, fresh whole blood was
taken from the same donors in SCE and CA test and
0.2 mL of 1/10 heparinized whole blood was added
into 2.5 mL of chromosome medium B (Biochrom F5023, Berlin, Germany). Peripheral lymphocytes were
incubated at 37 °C for 68 h (10). Cells were treated
with 25, 50, 75, and 100 μg/mL concentrations of BPO
for 24 (test substance was added 44 h after initiating
the culture) and 48 h (test substance was added 20 h
after initiating the culture). Cytochalasin B (Sigma)
was added at the 44th h of incubation to a final
concentration of 6 μg/mL to block cytokinesis and
thus binucleated cells were obtained. Cells were
harvested by centrifugation at the end of the
incubation period according to Rothfuss et al. (10).
Accordingly, the cells were treated with hypotonic
17
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solution (0.4% KCl) at 37 °C for 10 min. Afterwards,
cells were centrifuged and fixed at room temperature
for 20 min 3 times. The first fixative was a mixture of
glacial acetic acid + methanol + 0.9% NaCl (1:5:6 v/v,
respectively); however, the second and third fixatives
were composed of methanol + glacial acetic acid (5:1
v/v), respectively. After the third fixative treatment
slides were prepared, air dried, and stained with 5%
Giemsa (in Sorensen buffer) for 15 min.
Binuclear cells and micronuclei were determined
according to the criteria of Titenko-Holland et al. (11)
and Fenech and Morley (12). In all subjects, 1000
binuclear cells were scored per donor to calculate the
micronucleus formation (totally 4000 binuclear cells
were scored per concentration).
Statistical significance
A t-test was utilized for statistical significance of
all parameters. Correlation and regression coefficients
were calculated in order to determine the doseresponse relationships in treatment groups.
Results
The genotoxicity and cytotoxicity of benzoyl
peroxide in human peripheral lymphocytes were
investigated according to 4 different concentrations

(25, 50, 75, and 100 μg/mL) and 5 different
parameters (SCE, CA, MN, MI, and PI) in 2 different
exposure periods (24 and 48 h).
The effects of BPO on SCE are summarized in
Table 1. BPO induced SCEs only at the highest
concentration for 48 h treatment when compared to
the control. In other words, BPO generally did not
induce SCEs.
BPO induced the CA at the 2 highest
concentrations (75 and 100 μg/mL) for 24 h treatment
period. However, at all concentrations for 48 h
treatment period when compared both with control
and solvent control (Table 2), because the percentage
of abnormal cells and CA/cell were significantly
higher than those in both the control and solvent
control. A dose-dependent increment was noted for
the percentage of abnormal cells and CA/cell for both
the 24 and 48 h treatment (r = 0.978, P < 0.05 for 24
h, Figure 2; r = 0.944, P < 0.05 for 48 h, Figure 3; r =
0.956, P < 0.05 for 24 h, Figure 4; r = 0.983, P < 0.05
for 48 h, Figure 5). According to these data, we can
infer that BPO is a clastogen.
BPO, in general, increased the MN formation
compared to both control and solvent control.
However, a statistically significant increase was only
detected at the highest concentration for 48 h

Table 1. Mean SCE values in human lymphocytes treated with benzoyl peroxide for 24 and 48 h.
Treatment
Test Substance
Control
DMSO (solvent control)
MMC (positive control)
BPO
BPO
BPO
BPO
DMSO (solvent control)
MMC (positive control)
BPO
BPO
BPO
BPO

Time (h)

Concentration (μg/mL)

Min-Max SCE

SCE/Cell ± SE

24
24
24
24
24
24
48
48
48
48
48
48

8 μL
0.25
25
50
75
100
8 μL
0.25
25
50
75
100*

2-21
2-15
25-92
1-18
2-23
3-23
3-15
2-17
62-137
2-20
2-26
2-21
2-23

7.99 ± 0.33
7.92 ± 0.69
55.67 ± 4.21
8.49 ± 0.82 c3
8.46 ± 0.74 c3
8.89 ± 0.58 c3
9.22 ± 0.50 c3
8.14 ± 0.73
95.38 ± 4.13
10.26 ± 1.20 c3
11.12 ± 1.01 c3
10.81 ± 1.28 c3
11.93 ± 1.20 a1c3

1)*: Due to high toxicity 77 cells were scored for SCE analysis.
2) a: significant from control; b: significant from solvent control; c: significant from positive control
a1b1c1: P < 0.05 a2b2c2: P < 0.01 a3b3c3: P < 0.001
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Table 2. Effect of benzoyl peroxide on CA in human lymphocytes during 24 and 48 h treatment.
Treatment

Structural CA

% cells with structural

Test substances
Time Concentration
(h)
(μg/mL)
Control
Solvent control (DMSO)
Positive con. (MMC)
BPO
BPO
BPO
BPO
Solvent con. (DMSO)
Positive con.(MMC)
BPO
BPO
BPO
BPO

24
24
24
24
24
24
48
48
48
48
48
48

Chromatid
type

Chromosome
type

CA ± SE

CA/cell ± SE

20
20
247
19
23
33
38
23
364
34
35
37
45

8
2
131
12
14
9
10
6
82
9
15
19
13

6.50 ± 0.64
5.50 ± 0.40
57.75 ± 5.66
7.25 ± 1.04 c3
8.75 ± 0.81 b1c3
10.00 ± 0.4 a2b2c3
12.75 ± 1.49 a1b1c3
7.00 ± 0.70
74.75 ± 6.21
9.75 ± 0.47 a2b2c3
11.75 ± 0.85 a2b1c3
12.25 ± 1.65 a1b1c3
16.50 ± 0.50 a3b3c3

0.07 ± 0.00
0.055 ± 0.00
0.94 ± 0.14
0.08 ± 0.00 c3
0.09 ± 0.00 b1c3
0.10 ± 0.00 a2b2c3
0.13 ± 0.01 a1b1c3
0.07 ± 0.00
1.16 ± 0.33
0.10 ± 0.00 a2b1c3
0.12 ± 0.00 a2b2c3
0.14 ± 0.01 a2b2c3
0.18 ± 0.00 a3b3c3

8 μL
0.25
25
50
75
100*
8 μL
0.25
25
50
75
100**

CA/Cell

14
12
10
8
6
4
2
0

y = 0.067x + 5.625
r = 0.978*
25

50
75
Concentration (µg/mL)

AC (%)

Figure 2. Regression line and correlation coefficient of dosedependent AC increase in human peripheral
lymphocytes treated with various concentrations of
benzoyl peroxide for 24 h. *P < 0.05.
18
16
14
12
10
8
6
4
2
0

y = 0.083x + 7.375
r = 0.944*

25

50
75
Concentration (µg/mL)

0.14
0.12
0.1
0.08
0.06
0.04
0.02
0

100

Figure 3. Regression line and correlation coefficient of dosedependent AC increase in human peripheral
lymphocytes treated with various concentrations of
benzoyl peroxide for 48 h. *P < 0.05.

y = 0.0006x + 0.06
r = 0.956*

25

100

50
75
Concentration (µg/mL)

100

Figure 4. Regression line and correlation coefficient of dosedependent CA/cell increase in human peripheral
lymphocytes treated with various concentrations of
benzoyl peroxide for 24 h. *P < 0.05.

CA/Cell

AC (%)

1) *357 cells were scored due to high toxicity
2) **310 cells were scored due to high toxicity
3) a: significant from control; b: significant from solvent control; c: significant from positive control
a1b1c1: P < 0.05 a2b2c2: P < 0.01 a3b3c3: P < 0.001

0.2
0.18
0.16
0.14
0.12
0.1
0.08
0.06
0.04
0.02
0

y = 0.01x + 0.07
r = 0.983*
25

50
75
Concentration (µg/mL)

100

Figure 5. Regression line and correlation coefficient of dosedependent CA/cell increase in human peripheral
lymphocytes treated with various concentrations of
benzoyl peroxide for 48 h. *P < 0.05.
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MN (%)

treatment (Table 3). It was observed that 24 h BPO
treatment induced a dose-dependent increase in
binuclear cells with micronuclei (r = 0.996, P < 0.01,
Figure 6).
BPO did not significantly contribute to the
reduction of the PI and MI when compared to control
and solvent control in the 24 h treatment period.
However, 48 h BPO treatment significantly decreased
the PI and MI when compared to control and solvent
control (Table 4). Furthermore, a dose-dependent
decrease in PI and MI was observed in cultures
treated with BPO for 24 and 48 h (r = –0.990, P < 0.01
for 24 h, Figure 7; r = –0.998, P < 0.01 for 48 h, Figure
8; r = –0.984, P < 0.05 for 24 h, Figure 9; r = –0.985, P
< 0.05 for 48 h, Figure 10). We can conclude that BPO
has cytotoxic effects on human peripheral
lymphocytes (especially in 48 h treatment).

y = 0.004x + 0.775
r = 0.996*

25

50
75
Concentration (µg/mL)

In the present study, SCEs were found to be
increased only at the highest concentration (100
μg/mL) for 48 h treatment following an exposure with
BPO. BPO was found to induce a 2-fold increase in
SCEs in the presence of metabolic activator in CHO
cells; however, it did not induce SCEs in the absence
of a metabolic activator in CHO cells (1). In addition,
BPO treatment resulted in a 1.2-fold increase in SCE
levels in V79 cells (1). As seen, our results are in
accordance with the results of other researchers. In
other words, BPO was unable to induce SCE without
metabolic activation. Furthermore, potassium

The aim of this study was to clarify the possible
genotoxicity events emerging from the treatment of
human peripheral lymphocytes with BPO using in
vitro SCE, CA, and MN assays. For this purpose,
human peripheral lymphocytes were exposed to 25,
50, 75, and 100 μg/mL of BPO in 2 different treatment
periods, 24 and 48 h.

Percent of binucleated cells bearing micronuclei in human lymphocytes treated with various concentrations of benzoyl peroxide
for 24 and 48 h.
Treatment

Test Substance
Control
DMSO (solvent control)
MMC (positive control)
BPO
BPO
BPO
BPO
DMSO (solvent control)
MMC (positive control)
BPO
BPO
BPO
BPO

Time (h)

Concentration (μg/mL)

24
24
24
24
24
24
48
48
48
48
48
48

8 μL
0.25
25
50
75
100
8 μL
0.25
25
50
75
100

a: significant from control; b: significant from solvent control; c: significant from positive control
a1b1c1: P < 0.05 a2b2c2: P < 0.01 a3b3c3: P < 0.001

20

100

Figure 6. Regression line and correlation coefficient of dosedependent increase in micronucleated binuclear cell
percentage in human peripheral lymphocytes treated
with various concentrations of benzoyl peroxide for 24
h. *P < 0.01.

Discussion

Table 3.

1.4
1.2
1
0.8
0.6
0.4
0.2
0

Percent of
micronucleated
cells (±SE)
0.59 ± 0.14
0.80 ± 0.10
6.50 ± 0.82
0.89 ± 0.13 c3
1.04 ± 0.16 c3
1.13 ± 0.19 c3
1.27 ± 0.21 c3
0.65 ± 0.12
43.62 ± 7.60
1.08 ± 0.22 c3
1.28 ± 0.24 c3
1.54 ± 0.29 a1c3
2.51 ± 0.29 a2b2c3
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Table 4. Proliferation index (PI) and mitotic index (MI) in human lymphocytes treated with benzoyl peroxide for 24 and 48 h.
Treatment
Test substance

Control
DMSO (solvent control)
MMC (positive control)
BPO
BPO
BPO
BPO
DMSO (solvent control)
MMC (positive control)
BPO
BPO
BPO
BPO

Time (h)

Conc. (μg/mL)

M1

M2

M3

PI ± SE

MI ± SE

24
24
24
24
24
24
48
48
48
48
48
48

8 μL
0.25
25
50
75
100
8 μL
0.25
25
50
75
100

42
27
45
36
50
61
113
52
184
83
103
140
189

113
90
164
91
118
142
138
98
202
177
202
190
172

245
283
191
275
233
197
149
250
14
140
95
70
39

2.51 ± 0.09
2.64 ± 0.04
2.37 ± 0.06
2.60 ± 0.04 c1
2.47 ± 0.13
2.31 ± 0.17
2.07 ± 0.26
2.50 ± 0.07
1.57 ± 0.06
2.15 ± 0.09 a1b1c2
1.98 ± 0.05 a2b1c2
1.83 ± 0.06 a2b2c1
1.62 ± 0.09 a2b2

6.35 ± 0.91
5.62 ± 0.59
4.59 ± 0.17
5.45 ± 0.52
4.77 ± 0.72
4.46 ± 0.68
3.56 ± 0.89
5.26 ± 0.62
2.64 ± 0.62
4.51 ± 0.46 a1c1
3.90 ± 0.64 a1
3.12 ± 0.50 a2b1
1.84 ± 0.51 a2b2

3

6

2.5

5

2

4
MI

PI

a: significant from control; b: significant from solvent control; c: significant from positive control
a1b1c1: P < 0.05 a2b2c2: P < 0.01 a3b3c3: P < 0.001

1.5

y = -0.007x + 2.8
r = -0.990*

1
0.5
0

1

25

50
75
Concentration (µg/mL)

100

0

2
MI

1.5
y = -0.006x + 2.33
r = -0.998*

1
0.5
25

50
75
Concentration (µg/mL)

100

Figure 8. Regression line and correlation coefficient of dosedependent decrease in PI in human peripheral
lymphocytes treated with various concentrations of
benzoyl peroxide for 48 h. *P < 0.01.

25

50
75
Concentration (µg/mL)

100

Figure 9. Regression line and correlation coefficient of dosedependent decrease in MI in human peripheral
lymphocytes treated with various concentrations of
benzoyl peroxide for 24 h. *P < 0.05.

2.5

PI

y = -0.023x + 6.055
r = -0.984*

2

Figure 7. Regression line and correlation coefficient of dosedependent decrease in PI in human peripheral
lymphocytes treated with various concentrations of
benzoyl peroxide for 24 h. *P < 0.01.

0

3

5
4.5
4
3.5
3
2.5
2
1.5
1
0.5
0

y = -0.035x + 5.54
r = -0.985*

25

50
75
Concentration (µg/mL)

100

Figure 10. Regression line and correlation coefficient of dosedependent decrease in MI in human peripheral
lymphocytes treated with various concentrations of
benzoyl peroxide for 48 h. *P < 0.05.
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bromate—a bleaching agent of flour—was
determined to induce SCEs in human peripheral
lymphocytes during 48 h treatment (13). Similarly,
nitrogen dioxide (NO2) in Chinese hamster V79-H3
cells (14), and NO2 and NO as a gaseous mixture in
human peripheral lymphocytes (15) were found to
induce SCEs. As seen, some of the flour bleaching
agents are also capable of inducing SCEs.
In the present study, BPO at the 2 highest
concentrations (75 and 100 μg/mL) for 24 h treatment
and at all concentrations for 48 h treatment was
determined to increase the CAs as compared to the
control and solvent control (in 24 and 48 h
treatments), and that increase was in a dosedependent manner (r = 0.978, P < 0.05 for 24 h; r =
0.944, P < 0.05 for 48 h). According to a report by
Ishidate et al. (2), BPO did not induce CAs in Chinese
hamster fibroblast cells. In our study, we employed the
half-dose of BPO as the highest concentration (100
μg/mL) when compared to the study by Ishidate et al.
(2). At this dose range, BPO was capable of inducing
CA for both 24 and 48 h treatment. The difference
between the results of the present study and others
comes from the difference in the cell lines used. In
addition, various researchers have found that different
bleaching agents were also capable of inducing CAs
(13-17). In the present study, we determined that BPO
mostly induces chromatid and chromosome type
breaks. Previous studies have shown that BPO was an
inducer of DNA single strand breaks via the
production of free radicals (1,18-23). Hazlewood and
Davies (24) determined that BPO treatment led to the
formation of benzoyloxyl and phenyl radicals, which
react with nucleobases, sugars, nucleosides,
nucleotides, DNA, and RNA. Furthermore, these
researchers defined that the benzoyl oxide radicals
were more potent than phenyl radicals in producing
strand breaks by cleaving H atoms in the sugarphosphate backbone of DNA. According to these
results, BPO induces phosphodiester bond breaks on
the sugar-phosphate backbone of DNA molecule via
benzoyloxide and phenyl radicals. Thus, chromatid
and chromosome type breaks occur as a result of this
event. Since the chromatid type breaks were more
common than the chromosome type breaks in this
study, we propose that BPO especially induces single
strand breaks in G1 phase.
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In the current study, we also detected that BPO
generally induced MN formation; however, that
increment was statistically significant only at the
highest concentration for 48 h treatment. In addition,
a dose-dependent increase in MN formation was
recorded for 24 h treatment (r = 0.996, P < 0.01).
However, intraperitoneal BPO treatment in ICP (SFF)
mice did not induce MN formation (3). Furthermore,
some of the chemicals used in flour bleaching like
BPO were found to be capable in inducing MN
formation (13,25-30). The above observations clearly
indicate that some of the bleaching agents are capable
of inducing MN formation and some of them are not.
In this study, PI and MI in cultures treated for 24
h were not significantly lower than those in the
control and solvent control; however, the decrease in
PI and MI was found to be dose dependent (PI, r = –
0.990, P < 0.01; MI, r = –0.984, P < 0.05). When
compared to control and solvent control for 48 h
treatment , BPO caused a significant reduction in
both PI and MI. That decrement was also dose
dependent (PI, r = –0.998, P < 0.001; MI, r = –0.985,
P < 0.05). In that case, we can deduce that BPO
treatment, especially for 48 h, is cytotoxic for human
peripheral lymphocytes. Babich et al. (31) reported
that 0.06 and 0.15 mM concentrations of BPO caused
cytotoxicity in human keratinocyte RHEK-1 cell lines.
Our study clearly correlates with the study by Babich
et al. (31). Saladino et al. (19) also reported that BPO
was cytotoxic in human bronchial epithelial cells. In
addition, potassium bromate, a flour bleaching agent,
was reported to be cytotoxic in human peripheral
lymphocytes (13). Results indicate that BPO and
potassium bromate are both cytotoxic on human
peripheral lymphocytes.
Conclusion
In this study, BPO generally did not induce SCE.
However, BPO dose-dependently induced CA in both
treatment periods. MN formation was dosedependently increased in the 24 h treatment. BPO was
found to be cytotoxic in this study. Similar findings
were reported by Saladino et al. (19) and Babich et al.
(31).
BPO was also used in acne medication; however, it
was discovered that BPO had no relationship with
skin cancer (32,33). Nevertheless, carcinogenicity
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studies with laboratory animals revealed that BPO,
administered in a mixture with various chemicals,
contributed to the initiation of cancer and is a
potential tumor initiator and promoter (34-38).
Moreover, a previous study showed that iron overload
enhances BPO mediated cutaneous tumor promotion
in mice (39).
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